Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: A case-control study

HIV Medicine

Volumn 11, Issue 6, 2010, Pages 353-359

  Nguemaim N F ^a   Mbuagbaw, J ^a,b   Nkoa, T ^a,c   Alemnji, G ^a   Teto G ^a   Fanhi, T ^a   Asonganyi, T ^a   Same Ekobo A ^d  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b University Teaching Hospital Yaounde   (Cameroon)

^c Yaounde Gynaeco Obstetric and Paediatric Hospital   (Cameroon)

^d UNIVERSITY OF DOUALA   (Cameroon)

Author keywords

Atherogenicity index; Highly active antiretroviral therapy na ve; HIV infection; Lipids

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CAMEROON; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; ENZYME ASSAYS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPIDS; MALE; MIDDLE AGED; SEX DISTRIBUTION; TRIGLYCERIDES; YOUNG ADULT;

EID: 77954582903     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00784.x     Document Type: Article

References (43)

1. Rapport sur l'épidémie Mondiale du VIH/SIDA. Programme commun des Nations Unies sur le VIH/SIDA 2008, 232:196-197. ONUSIDA.
2. Ministry of Public Health and Cameroon National AIDS Control Committee., Preliminary results of the demographic and health survey (DHS-III). Ministry of Public Health, Yaoundé, Cameroon. 2004
3. Girard PM, Katlama C, Pialoux G. VIH/SIDA Edition 2000, Broché, Paris, 542p
4. Pichard E, Beyout J, Delmont J, Marchou B. Malintrop Afrique: manuel de maladies infectueuses pour l'Afrique. Paris. John Libbey Eurotext 2002, 455-468.
5. Lando G, Mbanya D, Magoue C. Lipid abnormalities in HIV/AIDS infected subjects in Cameroon., Yaounde, Cameroon 2001 [Abstract p 89]
6. Danwe C, Atchou G, Nkam M. Effects of antiretroviral therapy on lipid metabolism in HIV/AIDS subjects in Cameroon. J Med Sci 2005, 5:78-82.
7. Oumarou A, Ngongang J, Mbanya D, Mbuagbaw J. Lipides et lipoprotéines des sujets Camerounais VIH positifs naïfs aux ARV. Sidanet 2008, 5:1014.
8. Hoffmann C, Jaeger H. Cardiology and AIDS-HAART and the consequences. Ann NY Acad Sci 2001, 946:130-144.
9. Harmon WG, Dadlani GH, Fisher SD, Lipshultz SE. Myocardial and pericardial disease in HIV. Curr Treat Options Cardiovasc Med 2002, 4:497-509.
10. Gallin JI, Kaye D, O'Learvy WM. Serum lipids in infection. N Engl J Med 1969, 281:1081-1086.
11. Fiser RH, Denniston JC, Beisel WR. Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J Infect Dis 1972, 125:54-60.
12. Lees RS, Fiser RH, Beisel WR, Bartelloni PJ. Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 1972, 21:825-833.
13. Rouzer CA, Cerami A. Hypertriglyceridemia associated with Trypanosoma bruceii infection in rabbits: role of impaired triglyceride disposal mechanism. Mol Biochem Parasit 1980, 2:31-38.
14. Kerttula Y, Weber TH. Serum lipid in viral and bacterial meningitis. Scand J Infect Dis 1986, 18:211-215.
15. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986, 32:142-145.
16. Sammalkorpy K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988, 37:859-865.
17. Chanu B. HPL chez les patients infectés par le VIH. Nouvelle Société Française d'Athérosclérose 2005, 1-9.
18. Allain CC, Poon LS, Chan CGS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
19. Warnick GR, Alberers JJ. Heparin-Mn2+quantification of high density-lipoprotein by ultrafiltration procedure for lipemic samples. Clin Chem 1978, 20:900-904.
20. Fruchard JC. Determination du cholesterol HDL. Rev Fr Lab 1987, 103:7-17.
21. Buccolo G, David H. Quantitative determination of serum triglyceride by the use of enzymes. Clin Chem 1973, 19:476.
22. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982, 28:2077-2080.
23. Friedewald WT, Levy RI, Frederickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:449-502.
24. ONUSIDA/OMS., Le point sur l'épidemie mondiale de VIH/SIDA 2000: p 2
25. CDC/OMS., Classification du CDC, primo-infection à VIH, diagnostic et prise en charge 1993: p 18
26. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992, 74:1045-1052.
27. Henry K, Melfroe H, Huebesch J, Hermundson J, Levine C, Daley J. Severe premature coronary artery disease protease inhibitors (letter). Lancet 1998, 351:1328.
28. Ducobu J, Payen MC. Lipides et SIDA. Rev Méd Brux 2000, 1:11-17.
29. Constans J, Pellegrin JL, Peuchant E. Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest 1994, 24:416-420.
30. McDonagh J, Fossel ET, Kradin RK, Dubinett SM, Laposata M, Hallaq YA. Effect of Tumor Necrosis Factor-α on peroxidation of plasma lipoprotein lipids in experimental animals and patients. Blood 1992, 80:3217-3226.
31. Owens BJ, Anantharamaiah GM, Kahlon JB, Srinivas RV, Compans RW, Segrest JP. Apolipoprotein A1 and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncitium formation. J Clin Invest 1990, 86:1142-1150.
32. Weinroth SE, Parenti DM, Simon GL. Wasting syndrome in AIDS: pathophysiologic mechanism and therapeutic approaches. Infect Agent Dis 1995, 4:76-94.
33. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989, 86:27-31.
34. Hall KA, Hendricks C, Blatt S, Hunter G. Lipid abnormalities in HIV seropositive patients. Amsterdam 1992 [abstract PuB7228]
35. Llobet P, Muga R, Tor J, Rey-Joly C, Pardo A, Sabria M. Lipid levels and HIV-1 infection in intravenous drug users. Amsterdam 1992 [abstract PuC8183]
36. Mildvan D, Machado SG, Wilets I, Grossberg SE. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992, 339:453-456.
37. Grunfeld C, Kotler DP, Shigenaga JK. Circulating interferon alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991, 90:154-162.
38. Zangerle R, Sarletti M, Weiss G, Wachter H, Fuchs D. Altered concentrations of plasma lipids and neopterin in HIV-1 infection. Berlin 1993 [abstract POB02-0926]
39. Lahdervirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patient with acquired immunodeficiency syndrome. Am J Med 1988, 85:289-291.
40. Reddy MM, Sorrell SJ, Lange M, Grieco MH. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. J Acq Immun Def Syndr 1998, 1:436-440.
41. Hommes M, Romiji JA, Godfried MH. Increased resting energy expenditure in human immunodeficiency virus-infected man. Metabolism 1990, 39:1186-1190.
42. Dworkin B, Seaton T, Wormser G. Tumor necrosis factor (TNF), metabolic rate, body composition, weight loss in HIV infected patients [Abstract]. Clin Res 1990, 38:361A.
43. Alemnji GA, Folefac E, Teto G, Nkengafac S, Mbuagbaw J, Asonganyi T. Normal physiological ranges for serum biochemical parameters among healthy Cameroonians. African J Health Sciences (in press)